These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 26788573)

  • 21. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular and neuropsychiatric risks of varenicline.
    Fidler L; Anand A; Stanbrook M
    Lancet Respir Med; 2016 Mar; 4(3):e9-e10. PubMed ID: 26973165
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular and neuropsychiatric risks of varenicline: too good to be true?
    Nielen JT; Burden AM
    Lancet Respir Med; 2015 Dec; 3(12):e38-9. PubMed ID: 26679025
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiovascular and neuropsychiatric risks of varenicline: too good to be true?
    Odeyale F; Udo I
    Lancet Respir Med; 2015 Dec; 3(12):e38. PubMed ID: 26679026
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular and neuropsychiatric risks of varenicline: too good to be true? - Authors' reply.
    Kotz D; Viechtbauer W; Simpson C; van Schayck OC; West R; Sheikh A
    Lancet Respir Med; 2015 Dec; 3(12):e40-2. PubMed ID: 26679028
    [No Abstract]   [Full Text] [Related]  

  • 26. Reframing the varenicline question: have anecdotes and emotional filters clouded our decision making?
    Leone FT; Schnoll R
    Lancet Respir Med; 2015 Oct; 3(10):736-7. PubMed ID: 26477552
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular Safety Warnings and the Prescribing of Varenicline: An Interrupted Time-series Analysis.
    Filion KB; Eberg M; Azoulay L
    Epidemiology; 2016 Jul; 27(4):e28-9. PubMed ID: 27046129
    [No Abstract]   [Full Text] [Related]  

  • 28. [Varenicline in nicotine replacement therapy: Does it really increase the risk of cardiovascular and neuropsychiatric events?].
    Seguí Díaz M
    Semergen; 2016 Sep; 42(6):e67-8. PubMed ID: 26805914
    [No Abstract]   [Full Text] [Related]  

  • 29. Parkinsonism related to varenicline in a patient during smoking cessation.
    Uca AU; Kozak HH; Uğuz F; Gümüş H
    J Clin Psychopharmacol; 2015 Jun; 35(3):355-7. PubMed ID: 25874917
    [No Abstract]   [Full Text] [Related]  

  • 30. Nicotine Toxicity in a Nursing Home Resident With Dementia Secondary to Nicotine Replacement Treatment.
    Khan S; Blanton MP; Chavez M
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27722025
    [No Abstract]   [Full Text] [Related]  

  • 31. A case of nicotine overdose-induced seizure on an inpatient psychiatric unit.
    Holoyda B; Fritz K; Xiong GL
    Ann Clin Psychiatry; 2016 Feb; 28(1):66-7. PubMed ID: 26554375
    [No Abstract]   [Full Text] [Related]  

  • 32. Commentary on Wagener et al. (2012): electronic cigarettes - the Holy Grail of nicotine replacement?
    Etter JF
    Addiction; 2012 Sep; 107(9):1550-2. PubMed ID: 22594671
    [No Abstract]   [Full Text] [Related]  

  • 33. Response to Anandarajan et al.: Manic exacerbation induced by nicotine patch.
    Filia SL; Gurvich CT; Baker AL; Kulkarni J
    Aust N Z J Psychiatry; 2012 May; 46(5):484-5. PubMed ID: 22472771
    [No Abstract]   [Full Text] [Related]  

  • 34. Smoking for the cardiac patient.
    LEVY RL
    Med Clin North Am; 1950 May; 34(3):697-703. PubMed ID: 15416307
    [No Abstract]   [Full Text] [Related]  

  • 35. Harmful effects of nicotine.
    Mishra A; Chaturvedi P; Datta S; Sinukumar S; Joshi P; Garg A
    Indian J Med Paediatr Oncol; 2015; 36(1):24-31. PubMed ID: 25810571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review: all forms of nicotine replacement therapy are effective for smoking cessation.
    Ahijevych K
    Evid Based Nurs; 2005 Jan; 8(1):13. PubMed ID: 15688487
    [No Abstract]   [Full Text] [Related]  

  • 37. Correction:
    BMJ Open; 2019 Oct; 9(10):e027569corr1. PubMed ID: 31624080
    [No Abstract]   [Full Text] [Related]  

  • 38. Considerations of statistical power and risk of bias question the strength of nicotine replacement therapy's effectiveness.
    Stanley TD
    J Clin Epidemiol; 2016 Nov; 79():169-170. PubMed ID: 27353054
    [No Abstract]   [Full Text] [Related]  

  • 39. Providing Nicotine Replacement Therapy in Focus Groups.
    Jones EE; Jarman KL; Goldstein AO
    Nicotine Tob Res; 2018 Feb; 20(3):399-400. PubMed ID: 28472370
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter to the Editor: New Study Raises Questions about Effectiveness of Nicotine Replacement Therapy.
    MacKenzie R; Rogers W
    Public Health Ethics; 2016 Jul; 9(2):229-230. PubMed ID: 27551307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.